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Reactions of CF3-enones with arenes under
superelectrophilic activation: a pathway to
trans-1,3-diaryl-1-CF3-indanes, new cannabinoid
receptor ligands†
Roman O. Iakovenko,a Anna N. Kazakova,a Vasiliy M. Muzalevskiy,b
Alexander Yu. Ivanov,c Irina A. Boyarskaya,a Andrea Chicca,d Vanessa Petrucci,d
Jürg Gertsch,d Mikhail Krasavin,*a Galina L. Starova,a Andrey A. Zolotarev,a
Margarita S. Avdontceva,a Valentine G. Nenajdenko*b and Aleksander V. Vasilyev*a,e
4-Aryl-1,1,1-triﬂuorobut-3-en-2-ones ArCHvCHCOCF3 (CF3-enones) react with arenes in excess of
Brønsted superacids (TfOH, FSO3H) to give, stereoselectively, trans-1,3-diaryl-1-triﬂuoromethyl indanes in
35–85% yields. The reaction intermediates, the O-protonated ArCHvCHC(OH+)CF3 and the O,C-diproto-
nated ArHC+CH2C(OH
+)CF3 species, have been studied by means of
1H, 13C, 19F NMR, and DFT calcu-
lations. Both types of the cations may participate in the reaction, depending on their electrophilicity and
electron-donating properties of the arenes. The formation of CF3-indanes is a result of cascade reaction
of protonated CF3-enones to form chemo-, regio- and stereoselectively three new C–C bonds. The
obtained trans-1,3-diaryl-1-triﬂuoromethyl indanes were investigated as potential ligands for cannabinoid
receptors CB1 and CB2 types. The most potent compound showed sub-micromolar aﬃnity for both
receptor subtypes with a 6-fold selectivity toward the CB2 receptor with no appreciable cytotoxicity
toward SHSY5Y cells.
Introduction
1,1,1-Trifluorobut-3-en-2-ones (CF3-enones) are important
fluorinated building blocks having rich chemistry and are
used frequently for preparation of practically valuable fluorine-
containing substances. Several approaches to synthesis of CF3-
enones have been developed.1 The combination of a conju-
gated carbon–carbon double bond and a CF3CO-group present
in these compounds, results in their unique electrophilic pro-
perties, leading to the reactions at either the carbonyl group2
or the double bond3 – or at both of these structural frag-
ments.4 CF3-enones are known to react with various O-, S-,
N-, C-nucleophiles to give numerous polyfunctional deriva-
tives, carbo- and heterocycles bearing a trifluoromethyl group.
Many of these have been shown to possess diverse biological
activities.5
In continuation of our previous studies of reactions of CF3-
alkynes in Brønsted superacids,6 and CF3-allyl alcohols under
action of Lewis acids,7 we became interested in studying of the
fate of CF3-enones 1a–h (Fig. 1) under similar superelectro-
philic activation. In a preliminary short communication8 we
showed that 1,1,1-trifluoro-4-phenylbut-3-en-2-one 1a reacted
with benzene, o-xylene, and veratrole in TfOH. We chose
Brønsted superacids (TfOH, FSO3H)
9 for significant enhance-
ment of electrophilic properties of the CF3-enones system by
protonation. The main goal of this work was to investigate the
protonation of butenones 1a–h in superacids, the subsequent
reactions of the resulting carbocations with arenes, as
†Electronic supplementary information (ESI) available: Figures of 1H, 13C, 19F
NMR spectra, X-ray data of obtained compounds, additional biological profile of
compounds 2a–h,l, details of DFT calculations. CCDC 1047066, 1047331,
1047468, 1047315, 1047593 and 1048565. For ESI and crystallographic data in
CIF or other electronic format see DOI: 10.1039/c5ob01072a
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π-nucleophiles, and to test physiological activity of the result-
ing trifluoromethylated compounds.
Results and discussion
DFT calculation of cations derived from of 4-aryl-1,1,1-
trifluorobut-3-en-2-ones
Protonation of conjugated enones9a,b or ynones9c in Brønsted
superacids proceeds in two steps: first, protonation of the carb-
onyl oxygen occurs, followed by the second protonation of an
unsaturated carbon–carbon bond. In the same way protonation
of the CF3-enones system of compounds 1 gives consequently
cations A and dications B (Scheme 1). The latter species are
considered as superelectrophiles.9b Both the O-protonated (A)
and the O,C-diprotonated (B) forms can be reactive electro-
philes. They have two carbocationic centers (at C2 and C4) that
may participate in further reactions.
To gain insight into the nature of formed electrophilic
species we decided to study the reaction of CF3-enones with
acids theoretically. In order to estimate the charge distribution
in these species (as well as their electrophilicity), we performed
DFT calculations for carbocations, derived from CF3-enones
1a–f (Scheme 1). Selected electronic characteristics of the
O-protonated forms (A1–A6), the O,C-diprotonated forms (B1–
B6) are presented in the ESI (Table S9†). The global electro-
philicity index can be used quite eﬀectively to sort various
electrophiles qualitatively and provide a good estimation of the
activity of electrophiles. This parameter is easily calculated
from the HOMO and LUMO levels.10
The data obtained show that the highest value of global
electrophilicity index ω 30.3–47.5 eV belongs to dications B1–B6
that is quite predictable for doubly charged species.9,11 Apart
from that, these dications have a large positive charge
(0.66–0.69e) and a great contribution of an atomic orbital in
the LUMO on C2 atom (18.2–34.6%) which indicates a com-
bined eﬀect of charge and orbital control on the reactivity of
that carbon atom. This also reveals that the O,C-diprotonated
species B should be extremely reactive electrophiles (super-
electrophiles9b) with the C2 atom being more reactive com-
pared to C4.
The O-monoprotonated cations A1–A6 also carry a bigger
positive charge on C2 (0.40–0.43e) atom compared to C4
(0.02–0.07e). However, the latter has a slightly bigger contri-
bution of atomic orbital to the LUMO (26.5–29.7%). It may
determine the predominance of orbital control in reactivity of
C4 atom for cations A1–A6.
Thus, the DFT calculations predict that in principle both
cationic species A and B derived from 1 (Scheme 1) may act as
electrophiles. The atom C2 is the reactive center in dications B.
Cations A may possess two centers (atoms C2 and C4) for the
reaction with nucleophiles.
NMR study of CF3-enone protonation in superacids
In order to confirm DFT predictions we investigated protona-
tion of CF3-enones in TfOH and FSO3H at various tempera-
tures by means of NMR. It was found that CF3-enones 1a,c,d,f,
h aﬀorded stable O-protonated species A1, A3, A4, A6, A7,
respectively, at temperatures below −20 °C. 1H, 13C, and 19F
NMR data of these carbocations and the corresponding start-
ing materials are given in the ESI (Table S1†). 13C NMR signals
of ions A1, A3, A4, A6, A7 were carefully assigned using HSQC
(C–H) experiments. The signal of proton bound to the carbonyl
oxygen was not detected, due to a quick proton exchange with
superacidic media.9 At higher temperatures (above −20 °C),
subsequent protonation of the carbon–carbon double bond
can take place and the corresponding superelectrophilic di-
cations B are formed. Unfortunately, we failed to detect these
dications in the NMR spectra, due to their extreme instability
and high reactivity, which is peculiar to superelectrophiles.9b
At higher temperatures (−20 to 0 °C), the spectral data pointed
out the formation of complex mixtures of oligomeric reaction
products (vide infra). In contrast to other CF3-enones, com-
pound 1h gave an extremely stable (even at 60 °C) and unreac-
tive cation A7.
Comparison of the spectra of aryl substituted cations A1,
A3, A4, A6 and their neutral precursors 1a,c,d,f revealed that
the signals corresponding to proton H4 and carbon C4 under-
Fig. 1 Starting CF3-enones 1a–h used in this study.
Scheme 1 Protonation of CF3-enones.
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went substantial downfield shifts: ΔδH ∼ 1.1–1.7 ppm in 1H
NMR and ΔδC ∼ 20–30 ppm in 13C NMR (Table S1† and Fig. 2).
Such spectral changes indicated a partial positive charge de-
localization on carbon C4 and contribution of the corresponding
resonance structure A′ (Table S1†). On the other hand, the car-
bonyl carbon C2 (in 13C NMR) underwent only slight upfield
shifts upon protonation which additionally argues in favor of
form A′. Apart from that, in 1H and 13C NMR spectra of species
A1, A3, A4, A6 the signals of the ortho- and meta-protons and
carbons of the aromatic ring are non-equivalent. This indicates
a contribution of another resonance structure A″ (Table S1†),
in which restricted rotation around the C4–Ci bond is possible.
This resonance form has a significant contribution in the case
of para-methoxy substituted cation A″6, in which the signal of
the Cp atom is shifted to 180.8 ppm, compared to 150.1 ppm
in the non-protonated starting material 1f (see Fig. 2).
Dimethylamino substituted cation is also characterized by
resonance A′7 (Table S1†).
Thus, NMR data indicates a significant delocalization of
positive charge from C2 to C4 in the O-protonated species A,
despite the fact that the DFT calculations did not predict a
substantial charge re-distribution (see Table S9†). These data
suggest that carbocations A are likely to react with nucleo-
philes primarily at C4.
Reaction of CF3-enones with arenes in superacids
Having gathered the NMR data relevant to the protonation of
CF3-enones 1, we proceeded to study the behavior of com-
pounds 1 in superacids. In TfOH at 20 °C, CF3-enones 1a–c,e
are converted quantitatively into mixtures of oligomers consist-
ing of at least 6 units of the starting butanone (according to
MALDI mass spectrometry data, see ESI†). Indeed, the
observed oligomerization is a likely fate for dications B formed
in the absence of intercepting nucleophiles in the reaction
medium.
We were then curious to see if addition of carbocation aro-
matic traps, such as benzene or other arenes, would change
the course of the transformation of butenones 1 in superacids
(Table 1 and Schemes 2 and 3). Under the conditions that give
rise to species A1 (−40 to −20 °C, FSO3H or TfOH), CF3-enones
1a demonstrated no appreciable conversion in the presence of
an excess amount of benzene (entries 5 and 7, Table 1). Also,
in TfOH cations A3 (at −20 °C) and A7 (even on heating up to
60 °C), derived from compounds 1c and 1h, correspondingly,
did not react with benzene. Thus, these particular O-proto-
nated forms (A1, A3, A7) are not reactive toward benzene under
these conditions.
The reaction of compound 1a with benzene in neat TfOH at
20 °C (i.e. when intermediate dication B1 is likely to be
formed) aﬀorded indane 2a in 84% yield (entry 1, Table 1). Use
of less amount of TfOH gave unsatisfactory results (entries 2
and 3). Compared to TfOH, other Brønsted (entries 4 and 6) or
Lewis (entries 8–11) acids were not as eﬃcient in promoting
the same transformation.
The obtained indane 2a is the result of a very deep trans-
formation of 1a, in which both carbons C2 and C4 participate
in the reaction. It should be pointed out that two molecules of
benzene participated in the reaction and three new carbon–
carbon bonds are formed. Also the stereochemistry of the reac-
tion is quite significant. According to the NMR data, only one
diastereomer is formed having trans-arranged phenyl groups
in a cyclopentane ring of the indane system.
For comparison, other conjugated enones, such as alkene
carbaldehydes or ketones,12a–c alkene carboxylic acids12d–j and
their chloro anhydrides12k,l or amides,12m–q undergo hydro-
arylation of the carbon–carbon double bond in reactions with
arenes under activation with Brønsted superacids, strong
Lewis acids or acidic zeolites. But in the reactions of these
enones the carbonyl group remains unaﬀected. Introduction
of an electron-withdrawing CF3-substituent into the enone
system of 1a leads to additional electrophilic activation of
carbonyl carbon C2, which takes part in the reaction with
benzene (Table 1). It should be also noted that for some
enones12f,q–t the formation of stable O,C-diprotonated species
(like dications B, Scheme 1) in superacids was detected by
means of NMR.
The structures of indanes 2 (vide infra) were unambiguously
determined by means of 1H, 13C, 19F NMR spectroscopy, high-
resolution mass-spectrometry, and X-ray (Fig. 4). The relative
stereochemistry of products 2 was established by NOESY
experiments (Fig. 3). It should be noted that this reaction is
highly stereoselective, leading to indane with exclusively trans-
orientation of aryl groups. In addition we studied the mole-
cular structure of 2a by X-ray crystallography. The structure
was totally in agreement with NMR data to confirm trans-orien-
tation of phenyl rings (see Fig. 4a).
An indane (indene) fragment is a very important structural
unit of a large number of bioactive and pharmaceutically inter-
esting molecules as well as modern catalysts for polymeriz-
ation. 2-Trifluormethylated indanes are an important type of
indane derivatives, which have been used in biological study
as well as precursors for indene synthesis. However, so far the
existing approaches to trifluoromethylated indanes have some
restrictions.12i,13 The synthesis proposed in this investigation
is quite straightforward to construct highly desirable
CF3-indane derivatives from arene and the corresponding
CF3-enones in one-pot sequence.
Having found the reaction conditions leading to the for-
mation of indane 2a (TfOH, 20 °C, 1 h) we decided to study
the scope of the reaction and possible mechanism of the trans-
formation. For this aim a set of arenes and CF3-enones 1a–h
were studied under conditions of superelectrophilic activation
(see the Experimental section). It was found that enone 1a
reacts in a similar way with other arenes, for example, o-xylene
and 1,2-dimethoxybenzene (veratrole) to form trifluoromethyl-
ated indanes 2b, 2c in high yields (Scheme 2). Similar adducts
2e–h were isolated in good to high yields by the reaction
of enone 1d with benzene, o- and m-xylenes and veratrole
(electron rich aromatics). Compound 2d was obtained from a
reaction of 1c with benzene. It should be pointed out that in
all cases we observed the highly stereoselective formation of
trifluoromethylated indanes. According to the reaction mech-
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Fig. 2 Comparison of 1H and 13C NMR spectra of 1f (CDCl3, 20 °C) and cation A6 (FSO3H, −60 °C).
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Table 1 Reactions of CF3-enone 1a with benzene (12 equiv.) under the action of various acids
Entry
Reaction conditions
Reaction products
(yield, %)Acid T, °C t, h
1 TfOH (50 equiv.) 20 1 2a (84%)a
2 TfOH (5 equiv.), CH2Cl2(co-solvent) 20 1 2a (8%)
a
3 TfOH (1 equiv.), CH2Cl2(co-solvent) 20 1 Traces of 2a
b
4 H2SO4 (750 equiv.) 20 18 2a (15%)
a
5 FSO3H (80 equiv.), SO2(co-solvent) −40 3 1a (100%)c
6 FSO3H (80 equiv.) 20 1 Oligomers
7 TfOH (50 equiv.) −20 3 1a (100%)c
8 AlBr3 (5 equiv.) 20 0.5 Oligomers
a
9 AlBr3 (5 equiv.), CH2Cl2(co-solvent) −40 1 1a (100%)c
10 AlCl3 (5 equiv.), CH2Cl2(co-solvent) 20 1 Oligomers
a
11 FeCl3 (5 equiv.) 20 1 1a (100%)
c
a Complete conversion of initial 1a. b Incomplete conversion (∼30%) of initial 1a. cQuantitative recovery of unreacted initial 1a.
Scheme 2 Reaction of CF3-enones 1a,c,d with electron rich aromatics.
Scheme 3 Stepwise addition of arenes to CF3-enones 1.
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anism (vide infra) the cyclization in the case of the reaction of
enones with aromatics having diﬀerent substituents could
result in formation of mixture of cyclization products, however
as a rule the reaction proceeds highly chemoselectively and the
cyclization proceeds into the most nucleophilic aromatic ring.
The structures of some indanes were confirmed using X-ray
data (Fig. 4).
We found that the reaction is extremely sensitive to steric
demands. To our surprise the reaction of enone 1d with
m-xylene resulted not in the expected product of the attack to
4-position of m-xylene but the formation of 2-trifluoromethyl-
ated indane 2g, bearing a 3,5-dimethylphenyl group at C-2
atom. According to X-ray data (Fig. 4d) this aromatic ring is
attached to the indane core exactly. We believe that this regio-
chemistry can be explained by high steric bulkiness of the CF3
group which has a quite significant conformation energy of
2.1 kcal mol−1.14 As a result in the case of the reaction with
m-xylene thermodynamically controlled electrophilic substitution
is observed.
For molecules of all studied compounds 2a,b,e,g,h (Fig. 4) a
pentagonal ring of the indane system is a regular envelope
with atoms C1, C3, C4, C5 as the base and C1, C2, C3 as the lid.
The angle between base and lid planes of the envelope change
from 35.66(9)° for 2g to 32.0(1)° for 2c. The CF3-group deviates
to the envelope lid (the angle of deviation changes weakly
from 110.6(1)° for 2h to 111.9(1)° for 2g). The benzene ring
plane of the indane system has no deviation from the envelope
base plate practically (limits are from 0.3(1)° for 2b to 3.1(1)°
for 2g). Planes of aryl substituents are bended to the envelope
base with angle 72.33(6)° for 2g–77.1(1)° for 2a and 66.74(9)°
for 2h–76.90(6)° for 2b of the indane system atoms C1 and C3,
correspondingly. The analysis of molecule conformations of
these five studied compounds (Fig. 4), having no substituents
at atom C2 of the indane system, and the published earlier
Fig. 3 1H, 1H NOESY (left) and 1H, 19F HOESY (right) correlations,
proving stereochemical conﬁguration of indanes 2.
Fig. 4 X-ray crystal structures of compounds 2a (a), 2b (b), 2e (c), 2g (d), 2h (e) (ellipsoid contour of probability levels are 50%).
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compounds show that variation of substituents at atoms
C1 and C3 of the indane system changes very slightly the con-
figuration of the indane core.13f,15
The formation of indanes 2 indicates that both electrophilic
carbons C2 and C4 of cationic intermediates A or B partici-
pated in the reaction. Interestingly, electron-rich substrates,
such as o-xylene or thiophene, reacted with CF3-enones 1a,c in
FSO3H at −80 to −60 °C, i.e. under the conditions that favor
the formation of O-protonated species A1, A3 (see Table S1†).
We also obtained very interesting results under these con-
ditions to give clues to the reaction mechanism. We were able
to stop reaction at the first step and isolate in very good yields
the products of hydroarylation of enones 2, which are most
probably the intermediates of this reaction formed on the first
step of the reaction sequence. For example, the reaction of
enone 1c with thiophene (−80 °C, FSO3H) gave only the corres-
ponding 3,3-diarylbutanone 3a in 77% yield (Scheme 3). The
reaction of CF3-enone 1e with benzene in FSO3H at −60 °C
gave CF3-enone 3b in 68% yield (Scheme 3). In addition we
confirmed that these types of compounds can be transformed
into indanes. For instance, the reaction of 3b with benzene in
TfOH at 20 °C gave the expected indane 2i in 76% yield
(Scheme 3).
All these data clearly demonstrate that cations A are gener-
ally able to react at C4 with electron rich arenes and hetero-
arenes. However, the highly electrophilic versions of these
cations, like A5 (based on its ω values presented in Table S9†)
generated from 1e, can also react with less nucleophilic arenes
like benzene, also at C4 (Scheme 3). Finally, we believe that the
reactions of CF3-enones 1a–d,f with benzene in TfOH at 20 °C
are likely to proceed via the intermediate formation of dica-
tions B.
Discussion on reaction mechanism
Analyzing DFT calculations obtained for cations A, B
(Table S9†), NMR (Table S1†) and experimental data (Table 1
and Schemes 2 and 3), we conclude that species A and B
initially can react with nucleophiles at C4 and C2 respectively.
Based on this conclusion, one can propose the following reac-
tion pathways for the transformation of CF3-enones 1 into
indanes 2 (Scheme 4). The reaction of arenes with cation A at
carbon C4 can give compound 3, and subsequent protonation
leads to formation of cation D. The latter one can react further
in two ways: intermolecularly, with the arene, to give rise to
compound 4, or intramolecularly – to aﬀord after cyclization
indanol 5. Compounds 4 and 5 may also be obtained via the
reaction of dication B with an arene at C2 to result in the for-
mation of cation E. Subsequent transformations of 4 and 5 can
proceed with an intermediate formation of cations F and G,
respectively, culminating in the formation of indanes 2.
Scheme 4 Possible mechanism of the transformation of CF3-enones 1 into indanes 2. DFT calculations of parameters of cation G1.
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In order to validate the abovementioned mechanistic
interpretation, we synthesized compounds 3c, 5a, 4a, 6a (see
their synthesis and X-ray structure of 13 in the ESI†) all of
which can be implicated as intermediates on route from 1 to
2, and exposed them in TfOH with an excess of benzene
(Scheme 5).
The reaction of diarylbutanone 3c with benzene under acti-
vation with triflic acid gave indane 2a in high yield. Analo-
gously compound 3b aﬀorded 2l (Scheme 3). Indanol 5a can
also be transformed into 2a under the same conditions in 79%
yield. Interestingly, while alkenol 6a had not initially been
thought to be an intermediate in the proposed mechanistic
rationale (Scheme 5), we also found it to give rise to 2a under
the reaction conditions. However, isolation of diarylbutanones
3 under lower temperature indicates that this route to the final
indanes is most probable, therefore participation of 6a can be
discussed as a minor reaction route. In contrast, compound 4a
was not transformed into indane 2a (Scheme 5), making us
question its involvement in the above transformations.
Thus, there are two most likely reaction pathways: (1)
through cation A to structures 3, D, 5, G, and 2; or (2) through
cation B to structures E, 5, G, and 2. Cation G is one of the key
intermediates of this reaction for both pathways. The addition
of an aromatic molecule to the latter leads to trans-orientation
of the bulky aromatic groups, probably due to steric reasons.
DFT calculation of charge distribution in cation G1 and its
geometry was done (see ESI†). Large positive charge (0.21e) is
localized on the reactive center C1 of the indane system
(Scheme 4). Geometry of this species exhibits that the cone
angle with the apex at atom C3 and ortho-protons of the phenyl
ring is around 120° (Scheme 4), revealing rather great steric
restriction for attack of an arene molecule from this side of the
indane plane. Apart from that, DFT calculations have
shown that diﬀerence between the Gibbs energies of cis- and
trans-isomers 2a is 1.1 kcal mol−1 in favor of the trans-isomer
(see ESI†).
Concerning mechanisms of superelectrophilic activation of
conjugated enones, in 1990s Shudo and Ohwada12a,b postu-
lated formation of reactive O,O-diprotonated at carbonyl
oxygen species, which may lie on reaction pathways. One may
not exclude the participation of the dications in reactions, but
up to the moment these species have not been yet detected by
NMR or other physical methods, contrary to reliably character-
ized O,C-diprotonated forms of enones.12f,q–t
Additionally we observed two unusual reactions for CF3-
enones 1f and 1g. In both cases, the formation of indane 2a
was observed (Scheme 6). That means that an exchange of
p-anisyl (for 1f) or n-BuO (for 1g) substituents takes place under
superacidic reaction conditions. In the case of butoxy enone
the transformation to 1a takes place and some examples of
similar transformations CF3-enones are known in the litera-
ture.1h,16 However, it is more diﬃcult to explain the results of
the reaction with 1f. It is clear that electrophilic substitution
with removal of anisole (good electrofuge) takes place.
However, it is most probable that the enone 1a is not the
major intermediate of the reaction because a mixture of cis-
and trans-indanes 2a is formed. In addition, substitution of
anisole may take place from the initially formed indane
structure.
Summarizing the discussion of the reaction mechanism,
one may conclude that both O-protonated A and O,C-diproto-
nated B species take part in the reactions of 1 with arenes in
superacids. The electrophilicity of these cations as well as its
match to the electron-donating properties of the arenes
Scheme 5 Transformations of compounds 3c, 5a, 4a, 6a with benzene
in TfOH (20 °C, 10 min).
Scheme 6 Reactions of compounds 1f, 1g with benzene in TfOH.
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defines the outcome of the reaction. Strong electrophilic
cations A react even with poor nucleophilic arenes, such as
benzene. On the other hand, cations A, having moderate elec-
trophilicity, react primarily with electron-rich arenes (xylenes,
veratrole, etc.). Dications B are highly reactive superelectro-
philes, reacting with all aromatic substrates. In some cases
this reaction may proceed through mixed mechanisms with
participation of both cations A and B.
Eﬀects of 1,3-diaryl-1-trifluoromethyl indanes on the
endocannabinoid system
The new trans-1,3-diaryl-1-trifluoromethyl indanes 2a–h,l,
which we succeeded in obtaining as individual substances in
this work, are distinctly lipophilic compounds (Table 2). With
the aim of investigating the biological eﬀects of this newly con-
ceived scaﬀold, we assessed the binding properties of these
compounds on cannabinoid receptors, which are the target of
endogenous molecules called endocannabinoids that are also
distinctly lipophilic.
The highly lipophilic N-arachidonoylethanolamine (AEA or
anandamide) and 2-arachidonoylglycerol (2-AG) are the most
abundant and well-studied endocannabinoids and exert their
biological activity primarily by binding to type-1 (CB1) and
type-2 (CB2) cannabinoid receptors.
17 Most of the non-
endogenous ligands for CB1 and CB2 are also characterized by
high lipophilicity, for example the phytocannabinoid Δ9-tetra-
hydrocannabinol (Δ9-THC) and the synthetic non-classical
cannabinoids – SR141716A,18 JWH01519 and LY32013520
(Fig. 5). It is the lipophilic nature of trans-1,3-diaryl-1-trifluoro-
methyl indanes and the obvious similarity with the above syn-
thetic cannabinoids (in terms of the arrangement of the
aromatic periphery – vide infra) that further supported our
hypothesis of investigating the potential binding aﬃnity of
these molecules toward cannabinoid receptors.
Eight compounds 2a, 2c, 2d–h,l were screened for their
ability to displace [3H]CP55,940 (the radiolabelled analogue of
CP55,940, a potent, non-selective classical CB1 and CB2
ligand21) from CB1 and CB2 receptors. To our delight, three
compounds (2c, 2e and 2h) showed a significant (higher than
50%) displacement of [3H]CP55,940 at the screening concen-
tration of 1 μM. In addition, none of these compounds showed
significant cytotoxicity at the concentration of 10 μM after
72 hours of incubation with SHSY5Y human neuroblastoma
cells (Fig. 6). Compound 2b was insoluble under the assay con-
ditions and could not be tested.
The binding properties of compound
Compounds 2c, 2e and 2h were further investigated by generat-
ing full concentration-dependent curves (Fig. 7). All three com-
pounds showed total displacement of the radioligand [3H]-
CP55,940 to both cannabinoid receptors with the most potent
compound (2h) displaying a Ki value (calculated applying the
Cheng–Prusoﬀ equation) of 120 nM towards the CB2 receptor
and a 6-fold selectivity vs. the CB1 receptor (Ki value of 750
nM) (Fig. 7). The highest aﬃnity shown by compound 2h
could be explained by an interaction with the receptor similar
to other non-classical synthetic cannabinoids (SR141716A
(rimonabant), JWH015 and LY320135 shown in Fig. 4), consi-
Table 2 clog P values calculated (using ACD/Labs 6.00 software) for trans-1,3-diaryl-1-triﬂuoromethyl indanes synthesized in this work
Compound clog P value Compound clog P value Compound clog P value
6.16 ± 0.64 6.62 ± 0.65 8.60 ± 0.66
8.00 ± 0.65 6.76 ± 0.65 6.23 ± 0.70
5.64 ± 0.69 8.60 ± 0.66 6.08 ± 0.65
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dering quite an eﬀective spatial overlay of 2h with these three
known CB1/CB2 ligands, especially with LY320135, suggesting
potentially similar functional signaling by our trans-diaryl
indanes (Fig. 8).23
The trifluoromethyl indanes 2a, 2c and 2d–h,l were also
tested for potential inhibition of the key components of the
endocannabinoid system such as the hydrolytic enzymes fatty
acid amide hydrolase (FAAH) for AEA and monoacylglycerol
lipase (MAGL) and α/β hydrolase domain (ABHDs) for 2-AG,
the oxidative enzyme cyclooxygenase-2 for 2-AG and arachido-
nic acid and the putative endocannabinoid membrane trans-
porter.24 Interestingly, the compounds showed negligible
eﬀects on all these targets (see ESI†), clearly indicating that
2c, 2e and 2h selectively bind to cannabinoid receptors,
particularly CB2 receptors which are highly promising pharma-
cological targets for treating inflammatory and neuropathic
pain25 and neurodegenerative diseases.26
Conclusions
Novel eﬃcient stereoselective synthesis of trans-1,3-diaryl-1-tri-
fluoromethyl indanes was developed on the basis of super-
electrophilic activation of 4-aryl-1,1,1-trufluorobut-3-en-2-ones
and subsequent reaction with arenes. The reaction inter-
mediates, O-protonated and O,C-diprotonated forms of 4-aryl-
1,1,1-trufluorobut-3-en-2-ones have been studied by 1H, 13C,
19F NMR, and DFT calculations. Both of these cations take part
in the reaction, depending on electrophilicity of the cations
and electron donating properties of arenes.
Fig. 5 Endogenous (AEA and 2-AG) and natural (Δ9-THC) and synthetic (SR141716A, JWH015 and LY320135) cannabinoid receptor ligands.
Fig. 6 (a) Binding properties of compounds 2a, 2c, 2d–h,l tested at the concentration of 1 μM to CB1 and CB2 receptors (N = 3: n = 6, data shown
are mean ± standard deviation); (b) cytotoxicity of the same compounds tested at 10 μM on SHSY5Y cells (SRB method,22 72 hours of incubation N =
2–3: n = 4–6, data shown are mean ± standard deviation).
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Among the novel trans-1,3-diaryl-1-trifluoromethyl indanes
obtained in this work, three moderately potent ligands of
cannabinoid receptors have been identified. The most potent
compound (2h) displayed a 120 nM aﬃnity toward CB2 recep-
tor and a 6-fold selectivity vs. CB1 receptor. In the absence of
cytotoxicity and any eﬀect on the other key components of the
endocannabinoid system, the new trans-1,3-diaryl-1-trifluoro-
methyl indane scaﬀold clearly has a value for the design on
Fig. 8 Spatial overlay of the structure of compound 2h (shown in grey) with (a) SR141716A, (b) JWH015 and (c) LY320135 – all shown in orange.
Fig. 7 Concentration-dependent binding curves and Ki values calculated for compounds 2c, 2e and 2h (N = 3–6: n = 9–18, data shown are mean ±
standard deviation for the binding curves and mean and 95% conﬁdence interval for Ki values).
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selective modulators of cannabinoid (in particular, CB2)
receptors.
Experimental
The NMR spectra of solutions of compounds in CDCl3 were
recorded on Bruker AVANCE III 400 (at 400, 376 and 100 MHz
for 1H, 19F and 13C NMR spectra respectively) or Bruker DPX
300 (at 300 and 75 MHz for 1H and 13C NMR spectra respecti-
vely) spectrometers at 25 °C. The residual proton-solvent peak
CDCl3 (δ 7.26 ppm) for
1H NMR spectra and the carbon signal
of CDCl3 (δ 77.0 ppm) for
13C NMR spectra were used as refer-
ences. NMR experiments in the superacids TfOH or FSO3H
were performed on a Bruker AVANCE III spectrometer (at 500,
476 and 125 MHz for 1H, 19F and 13C NMR spectra respecti-
vely). NMR spectra in superacids were referenced to the signal
of CH2Cl2 added as an internal standard: δ 5.32 ppm for
1H
NMR spectra, and δ 53.84 ppm for 13C NMR spectra. HRMS
was carried out on instruments Bruker maXis HRMS-ESI-QTOF
and Varian 902-MS MALDI Mass Spectrometer. Chromato-
mass-spectrometry data were obtained using Shimadzu
QP-2010 Ultra with a SPB-1 SULFUR capillary column (30 m ×
0.32 mm), thickness of the stationary phase being 1.25 μm.
The preparative reactions were monitored by thin-layer
chromatography carried out on silica gel plates (Alugram SIL
G/UV-254), using UV light for detection. Preparative column
chromatography was performed on silica gel 60 Merck with
hexane–ethyl acetate mixture elution.
For single crystal X-ray diﬀraction experiments, crystals of
all compounds were fixed on a micro mount and placed on an
Agilent Technologies Excalibur Eos diﬀractometer using
monochromated MoKα radiation (2a, 2b) and on Agilent
Technologies SuperNova using a monochromated CuKα
(2e, 2g, 2h) (Oxford Diﬀraction) diﬀractometer and measured
at a temperature of 100 K. The structures have been solved by
direct methods SHELXS and refined for unique reflections
with |Fo| ≥ 4σF by means of the SHELXL program27 incorpor-
ated in the OLEX2 program package.28 The carbon-bound
H atoms were placed in calculated positions and were included
in the refinement in the ‘riding’ model approximation, with
Uiso(H) set to 1.5Ueq(C) and C–H 0.96 Å for the CH3 groups,
Uiso(H) set to 1.2Ueq(C) and C–H 0.97 Å for the CH2 groups,
Uiso(H) set to 1.2Ueq(C) and C–H 0.93 Å for the CH groups.
CCDC 1047066 (2a), CCDC 1047331 (2b), CCDC 1047468 (2e),
CCDC 1047315 (2g), CCDC 1047593 (2h) contain the sup-
plementary crystallographic data.
All computations has been carried out at the DFT/HF
hybrid level of theory using Becke’s three-parameter hybrid
exchange functional in combination with the gradient-cor-
rected correlation functional of Lee, Yang, and Parr (B3LYP) by
using GAUSSIAN 2003 program packages.29 The geometry
optimization was performed using the 6-311+G(2d,2p) basis
set. The Hessian matrix was calculated analytically for the opti-
mized structures in order to prove the location of correct
minima (no imaginary frequencies) and to estimate the
thermodynamic parameters. Enthalpies and Gibbs free
energies were calculated at 25 °C.
Starting 4-aryl-1,1,1-trufluorobut-3-en-2-ones 1a–i were pre-
pared according to the literature procedures.1b,f–h
General procedure for reaction of compounds 1a–g with
arenes in superacids CF3SO3H or FSO3H
Synthesis of compounds 2a–n, cis-2a, 3a,b. CF3-enone 1a–g
(0.23 mmol) was added to a mixture of TfOH (at 20 °C)
(1–2 mL) or FSO3H (at −80 to −60 °C) (1 mL, co-solvents SO2
or CH2Cl2) with benzene (0.3 ml) or another arene (1 mmol).
The reaction mixture was magnetically stirred for 1–2 h. Then
in the case of TfOH the mixture was poured into ice water
(30 mL) and extracted with chloroform (2 × 40 mL). The
extracts were combined, washed with water, a saturated
aqueous solution of NaHCO3, water again, and dried over
Na2SO4. The solvent was distilled oﬀ under reduced pressure,
and the residue was recrystallized from methanol or subjected
to chromatographic separation on silica gel using hexane–
ethyl acetate mixtures (20 : 1 to 10 : 1) as an eluent. For FSO3H
the reaction mixture was quenched with frozen −80 °C concen-
trated aqueous HCl (10 mL), diluted with water (20 ml), then
extracted and worked up as described above. Yields of
the obtained compounds are given in Table 1 and Schemes 2,
3 and 6.
(1RS,3RS)-1-Trifluoromethyl-1,3-diphenylindane (2a). Yield
65 mg, 84%. Colorless solid, mp 106–108 °C (MeOH). 1H NMR
(CDCl3, 400 MHz) δ, ppm: 2.80 (dd, J = 11.2 Hz, 12.5 Hz, 1H),
3.05 (dd, J = 6.8 Hz, 12.5 Hz, 1H), 4.09 (dd, J = 11.2 Hz, 6.8 Hz,
1H), 6.95 (d, J = 7.5 Hz, 1H), 7.21 (d, J = 6.8 Hz, 2H), 7.29 (d, J =
7.2 Hz, 1H), 7.25–7.38 (m, 8H), 7.40 (t, J = 7.5 Hz, 1H), 7.64 (d,
1H, J = 7.9 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 46.9 (CH),
48.3 (CH2), 60.8 (q, C̲–CF3, J = 26.4 Hz), 125.7, 125.9 (d, J =
1.3 Hz), 127.17, 127.20, 127.6 (q, CF3, J = 281.5 Hz), 128.0,
128.5, 128.6 (2CH), 128.8, 129.0, 137.5, 140.7 (d, J = 1.4 Hz),
142.8, 147.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −69.16 (s,
CF3). MS (GC-MS, EI), m/z (Irel., %) – 338 M
+ (3), 260 (100), 191
(50). HRMS: C22H17F3 found 338.1285 M
+; calcd 338.1282.
(1SR,3RS)-1-Trifluoromethyl-1,3-diphenylindane (cis-2a).
Obtained as a 1 : 1 mixture with indane 2a. Yield 25 mg, 80%.
1H NMR (CDCl3, 400 MHz) δ, ppm: 2.52 (dd, J = 8.4 Hz,
14.4 Hz, 1H), 3.43 (dd, J = 8.4 Hz, 14.4 Hz, 1H), 4.63 (t, J =
8.4 Hz, 1H), 7.08 (d, J = 7.0 Hz, 1H), 7.15 (d, J = 7.1 Hz, 2H),
7.20–7.24 (m, 1H), 7.25–7.35 (m, 8H), 7.47 (d, J = 7.7 Hz, 2H).
13C NMR (CDCl3, 100 MHz) δ, ppm: 48.1 (CH2), 49.9 (CH), 61.7
(q, C̲–CF3, J = 25.3 Hz), 127.6 (q, CF3, J = 281 Hz), 141.2,
141.51, 141.52, 144.4, 148.4. 19F NMR (CDCl3, 376 MHz)
δ, ppm: −69.36 (s, CF3). MS (GC-MS, EI), m/z (Irel., %) – 338 M+
(100), 269 (100), 260 (90), 191 (100). HRMS: C22H17F3 found
338.1285 M+; calcd 338.1282.
(1RS,3RS)-1-Trifluoromethyl-5,6-dimethyl-1-(3,4-dimethylphenyl)-
3-phenylindane (2b). Yield 80 mg, 77%. Colorless solid, mp
106–108 °C (MeOH). 1H NMR (CDCl3, 300 MHz) δ, ppm: 2.25
(s, 3H, CH3), 2.28 (s, 6H, 2CH3), 2.38 (s, 3H, CH3), 2.74 (dd,
1H, J = 12.5 Hz, 11 Hz), 3.00 (dd, 1H, J = 6.5 Hz, 12.5 Hz), 4.06
(dd, 1H, J = 6.5 Hz, 11 Hz), 6.72 (s, 1H), 7.01–7.12 (m, 2H), 7.17
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(s, 1H), 7.22–7.25 (m, 2H), 7.29–7.36 (m, 4H). 13C NMR (CDCl3,
75 MHz) δ, ppm: 19.3 (CH3), 19.9 (CH3), 20.1 (CH3), 47.0 (CH2),
47.8 (CH), 60.1 (q, C̲–CF3, J = 25 Hz), 125.8, 126.0, 126.3, 126.5,
126.8, 128.5, 128.6, 129.5, 129.55, 129.6 (q, CF3, J = 275 Hz),
135.2, 135.3, 136.2, 136.4, 138.4, 143.2, 144.8. 19F NMR (CDCl3,
470 MHz) δ, ppm: −69.19 (s, CF3). MS (GC-MS, EI), m/z (Irel.,
%) – 394 (5) [M]+, 325 (30), 289 (100), 219 (34). HRMS:
C26H25F3 found 394.1911 M
+; calcd 394.1908.
(1RS,3RS)-1-Trifluoromethyl-5,6-dimetoxy-1-(3,4-dimetoxyphenyl)-
3-phenylindane (2c). Yield 77 mg, 75%. Colorless solid, mp
104–108 °C (MeOH). 1H NMR (CDCl3, 500 MHz) δ, ppm: 2.68
(dd, 1H, J = 11 Hz, 12.5 Hz), 2.90 (dd, 1H, 12.5 Hz, 7 Hz), 3.72
(s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.91 (s,
3H, OCH3), 4.04 (dd, 1H, J = 7 Hz, 11 Hz), 6.40 (s, 1H),
6.70–6.78 (m, 2H), 6.88 (s, 1H), 7.03 (s, 1H), 7.18 (d, 2H, J =
7 Hz), 7.22–7.25 (m, 1H), 7.31 (t, 2H, J = 7.4 Hz). 13C NMR
(CDCl3, 125 MHz) δ, ppm: 47.8 (CH2), 48.2 (CH), 55.82 (OMe),
55.83 (OMe), 56.0 (OMe), 56.3 (OMe), 60.2 (q, C̲–CF3,
J = 26 Hz), 107.9, 108.1, 110.6, 111.7, 121.0, 127.0, 128.4, 128.7,
128.8, 130.5, 132.4, 133.4 (q, CF3, J = 275 Hz), 139.6, 143.1,
148.56, 148.62 (2C), 150.0. 19F NMR (CDCl3, 470 MHz) δ, ppm:
−69.22 (s, CF3). MS (GC-MS, EI), m/z (Irel., %) – 458 M+ (32),
389 (33), 320 (100). HRMS: C26H25F3O4 found 458.1708 M
+;
calcd 458.1705.
(1RS,3RS)-1-Trifluoromethyl-6-methyl-1,3-diphenylindane (2d).
Yield 31 mg, 35%. Colorless solid, mp 102–105 °C (MeOH). 1H
NMR (CDCl3, 400 MHz) δ, ppm: 2.38 (s, 3H, CH3), 2.68 (dd,
1H, J = 12.5 Hz, 11 Hz), 2.93 (dd, 1H, J = 6.8 Hz, 12.5 Hz), 3.96
(dd, 1H, J = 6.8 Hz, 11 Hz), 6.75 (d, 1H, J = 7.8 Hz), 7.07 (d, 1H,
J = 7.8 Hz), 7.11–7.14 (m, 9H), 7.18 (s, 1H), 7.34 (s, 1H). 13C
NMR (CDCl3, 100 MHz) δ, ppm: 21.7 (CH3), 47.2 (CH2), 47.9
(CH), 60.8 (q, C̲–CF3, J = 29 Hz), 124.7, 125.4, 126.3 (q,
C̲H ̲CCCF3, J = 1.1 Hz), 127.1, 128.0, 128.5, 128.5 (q, CF3, J =
256 Hz), 128.6 (2CH), 128.8, 129.8, 137.0, 137.7, 140.8, 143.1,
144.6. 19F NMR (CDCl3, 376 MHz) δ, ppm: −69.01 (s, CF3). MS
(GC-MS, EI), m/z (Irel., %) – 352 M
+ (15), 274 (100), 205 (40).
HRMS: C23H19F3 found 352.1441 M
+; calcd 352.1439.
(1RS,3RS)-3-(4-Chlorophenyl)-1-trifluoromethyl-1-phenylindane
(2e). Yield 53 mg, 80%. Colorless solid, mp 109–112 °C
(MeOH). 1H NMR (CDCl3, 400 MHz) δ, ppm: 2.72 (dd, 1H, J =
12.5 Hz, 11.2 Hz), 3.03 (dd, 1H, J = 12.5 Hz, 6.8 Hz), 4.06 (dd,
1H, J = 11.2 Hz, 6.8 Hz), 6.93 (d, 1H, J = 7.6 Hz), 7.14 (d, 2H, J =
8.4 Hz), 7.36–7.28 (m, 8H), 7.40 (t, 1H, J = 7.5 Hz), 7.63 (d, 1H,
J = 7.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 46.9 (q, CH2,
J = 1.3 Hz), 47.7 (CH), 60.8 (q, C ̲–CF3, J = 25 Hz), 125.5, 126.0
( J 1.2 Hz), 127.4, 127.6 (q, CF3, J = 281 Hz), 128.1, 128.5, 128.6
(q, J = 0.8 Hz), 129.0, 129.9, 133.0, 137.3, 140.7 (q, J = 1.3 Hz),
141.9, 147.0. 19F NMR (CDCl3, 376 MHz) δ, ppm: −69.19 (s,
CF3). MS (GC-MS, EI), m/z (Irel., %) – 372 M
+ (15), 337 (15), 303
(10), 294 (100). HRMS: C22H16F3Cl found 372.0893 M
+; calcd
372.0893.
(1RS,3RS)-3-(4-Chlorophenyl)-1-trifluoromethyl-5,6-dimethyl-1-
(3,4-dimethylphenyl)indane (2f ). Yield 50 mg, 57%. Colorless
solid, mp 113–115 °C (MeOH). 1H NMR (CDCl3, 300 MHz) δ,
ppm: 2.23 (s, 3H, CH3), 2.25 (s, 6H, 2CH3), 2.36 (s, 3H, CH3),
2.65 (dd, 1H, J = 12.4 Hz, 10.6 Hz), 2.96 (dd, 1H, J = 10.6 Hz,
6.5 Hz), 4.02 (dd, 1H, J = 6.5 Hz, 10.6 Hz), 6.67 (s, 1H), 7.00 (d,
1H, J = 8.0 Hz), 7.07 (d, 1H, J = 8.0 Hz), 7.14 (m, 3H), 7.30 (d,
2H, J = 8.4 Hz), 7.36 br (s, 1H). 13C NMR (CDCl3, 100 MHz)
δ, ppm: 19.5 (CH3), 20.1 (2CH3), 20.3 (CH3), 47.2 (d, CH2, J =
0.8 Hz), 47.4 (CH), 60.3 (q, C̲–CF3, J = 26.2 Hz), 126.1, 126.3 (d,
J = 4.9 Hz), 126.8 (d, J = 0.7 Hz), 127.8 (q, CF3, J = 282 Hz),
128.9, 126.8, 129.6, 130.0, 132.7, 135.1, 135.8, 136.46, 136.63,
137.5, 141.9, 144.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −69.22
(s, CF3). MS (GC-MS, EI), m/z (Irel., %) – 428 M
+ (10), 359 (7),
322 (100), 253 (12). HRMS: C26H24F3Cl found 428.1514
M+; calcd 428.1519.
(1RS,3RS)-3-(4-Chlorophenyl)-1-trifluoromethyl-4,6-dimethyl-1-
(3,5-dimethylphenyl)indane (2g). Yield 46 mg, 54%. Colorless
solid, mp 103–105 °C (MeOH). 1H NMR (CDCl3, 300 MHz) δ,
ppm: 1.71 (s, 3H, CH3), 2.27 (s, 6H, 2CH3), 2.41 (s, 3H, CH3),
2.60 (dd, 1H, J = 13.2 Hz, 9.8 Hz), 3.01 (dd, 1H, J = 13.2 Hz,
7.6 Hz), 4.15 (t, 1H, J = 8.6 Hz), 6.85 (s, 2H), 6.96 (s, 1H),
6.97 (s, 1H), 7.08 (d, 2H, J = 8.2 Hz), 7.22 (s, 1H), 7.27 (d, 1H,
J = 8.2 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 19.9 (CH3),
21.5 (CH3), 21.7 (2CH3), 47.5 (CH), 48.0 (d, CH2, J = 1 Hz), 60.7
(q, C̲–CF3, J = 26.2 Hz), 124.3 (d, J = 1.1 Hz), 126.0 (d, J =
0.9 Hz), 127.8 (q, CF3, J = 282 Hz), 129.0, 129.4, 129.6, 132.0,
132.3, 135.3, 137.5, 137.8, 138.8, 141.3, 141.58, 141.59, 143.5.
19F NMR (CDCl3, 376 MHz) δ, ppm: −68.72 (s, CF3). MS
(GC-MS, EI), m/z (Irel., %) – 428 [M]
+ (30), 359 (15), 322 (100),
253 (20). HRMS: C26H24F3Cl found 428.1517 M
+; calcd
428.1519.
(1RS,3RS)-3-(4-Chlorophenyl)-1-trifluoromethyl-5,6-dimethoxy-
1-(3,4-dimethoxyphenyl)indane (2h). Yield 64 mg, 73%. Color-
less solid, mp 111–114 °C (MeOH). 1H NMR (CDCl3, 400 MHz)
δ, ppm: 2.65 (dd, 1H, J = 12.6 Hz, 10.6 Hz), 2.91 (dd, 1H, J =
12.6 Hz, 6.9 Hz), 3.77 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.86
(s, 3H, OCH3), 3.94 (s, 3H, OCH3), 4.05 (dd, 1H, J = 10.6 Hz, 6.8
Hz), 6.38 (s, 1H, H), 6.73 (dd, 1H, J = 8.5 Hz, 1.8 Hz), 6.88 (d,
1H, J = 8.5 Hz), 6.89 (d, 1H, J = 1.8 Hz), 7.05 (s, 1H), 7.14 (d,
2H, J = 8.4 Hz), 7.31 (d, 2H, J = 8.4 Hz). 13C NMR (CDCl3,
100 MHz) δ, ppm: 47.7 (CH), 48.0 (CH2), 55.97 (OMe), 55.99
(OMe), 56.12 (OMe), 56.40 (OMe), 60.4 (q, C̲–CF3, J = 26.3 Hz),
107.8, 108.3 (d, J = 0.8 Hz), 110.7, 111.8, 121.1, 127.7 (q, CF3,
J = 282 Hz), 129.4, 129.9, 130.5, 132.5, 132.9, 139.2, 141.8,
148.8 (q, J = 4.1 Hz), 150.3. 19F NMR (CDCl3, 376 MHz) δ, ppm:
−69.25 (s, CF3). MS (GC-MS, EI), m/z (Irel., %) – 492 [M]+ (50),
423 (40), 354 (100). HRMS: C26H24F3O4Cl found 492.1318 M
+;
calcd 492.1315.
(1RS,3RS)-1-Trifluoromethyl-5-methoxy-1,3-diphenylindane (2i).
Yield 11 mg, 76%. Colorless solid, mp 102–104 °C (MeOH). 1H
NMR (CDCl3, 400 MHz) δ, ppm: 2.79 (t, 1H, J = 12.5 Hz), 3.01
(dd, 1H, J = 12.5 Hz, 11 Hz), 3.74 (3H, OMe), 4.03 (dd, 1H, J =
11 Hz, 12.5 Hz), 6.45 (d, 1H, J = 2.4 Hz), 6.93 (dd, 1H, J =
8.4 Hz, 2.4 Hz), 7.19–7.23 (m, 2H), 7.28 (d, 1H, J = 7.1 Hz),
7.30–7.36 (m, 7H), 7.51 (d, 1H, J = 8.4 Hz). 13C NMR (CDCl3,
100 MHz) δ, ppm: 47.3 (CH2), 48.4 (CH), 55.6 (OMe), 60.2 (q,
C̲–CF3, J = 29.5 Hz), 110.6, 113.5, 126.6 (q, C̲H ̲CCCF3, J = 1 Hz),
127.2, 127.7 (q, CF3, J = 282 Hz), 128.0, 128.4, 128.6 (d, J =
0.8 Hz), 128.7, 128.9, 132.8, 138.0, 142.7, 149.2, 160.6. 19F
NMR (CDCl3, 376 MHz) δ, ppm: −69.46 (s, CF3). MS (GC-MS,
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EI), m/z (Irel., %) – 368 M
+ (80), 299 (100), 290 (25), 221 (30).
HRMS: C23H19F3O found 368.1385 M
+; calcd 368.1388.
1,1,1-Trifluoro-4-(4-methylphenyl)-4-(thiophen-2-yl)butan-2-one
(3a). Yield 44 mg, 77%. Yellow oil. 1H NMR (CDCl3, 400 MHz)
δ, ppm: 2.32 (s, 3H, OMe), 3.40–3.52 (m, 2H, AB-system, CH2),
4.86 (t, 1H, CH, J = 7.3 Hz), 6.83 (d, 1H, J = 3.5 Hz), 6.91 (dd,
1H, J = 5 Hz, 3.5 Hz), 7.10–7.19 (m, 5H). 13C NMR (CDCl3,
100 MHz) δ, ppm: 21.2 (CH3), 40.0 (CH), 44.0 (CH2), 115.5
(CF3, J = 292 Hz), 124.40, 124.27, 126.9, 127.4, 129.7, 137.2,
139.3, 146.9, 189.0 (q, C̲O ̲CF3, J = 35.7 Hz). 19F NMR (CDCl3,
376 MHz) δ, ppm: −79.39 (s, CF3). MS (GC-MS, EI), m/z (Irel.,
%) – 298 M+ (20), 283 [M − CH3]+ (15), 229 [M − CF3]+ (7), 187
[M − CH2COCF3]+ (100). HRMS: C14H13F3OS found 286.0640
M+; calcd 286.0640.
1,1,1-Trifluoro-4-(3-methoxyphenyl)-4-phenylbutan-2-one (3b).
Yield 44 mg, 68%. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 3.48 (d, 2H, CH2, J = 7.5 Hz), 3.77 (s, 3H, OMe), 4.63 (t,
1H, CH, J = 7.5 Hz), 6.73–6.77 (m, 2H), 6.82 (d, 1H, J = 7.8 Hz),
7.20–7.25 (m, 4H), 7.28–7.34 (m, 2H). 13C NMR (CDCl3,
100 MHz) δ, ppm: 42.6 (CH2), 44.7, 55.3, 109.8, 112.0, 115.6
(CF3, J = 292 Hz), 117.5, 127.1, 127.6, 129.0, 130.0, 142.4,
144.2, 160.0, 189.4 (q, C̲O ̲CF3, J = 35.5 Hz). 19F NMR (CDCl3,
376 MHz) δ, ppm: −79.38 (s, CF3). MS (GC-MS, EI), m/z (Irel.,
%) – 308 M+ (100), 239 (23), 197 (95). HRMS: C17H15F3O2
found 308.1021 M+; calcd 308.1024.
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